期刊文献+

尿毒清颗粒治疗慢性肾脏病4期患者疗效观察 被引量:10

Clinical Observation of Niaoduqing Granules in Treatment of Chronic Kidney Disease Periodicals 4
原文传递
导出
摘要 目的观察尿毒清颗粒对慢性肾脏病4期的疗效。方法 36例CKD4期患者随机分为对照组、尿毒清常规剂量组、尿毒清大剂量组,对照组给予基础治疗,常规剂量组每日口服25g尿毒清颗粒,大剂量组每日口服40g尿毒清颗粒,疗程为3个月。检测各组治疗前后的血尿素氮(BUN)、肌酐(Scr)、尿酸(UA)、血红蛋白(Hb)、肾小球举步滤过率(e GFR)。结果 3组临床疗效比较差异有统计学意义(P<0.05);尿毒清不同剂量组的BUN、Scr、UA、e GFR均较治疗前下降,而Hb无改变,且分别与对照组治疗后比较,差异有统计学意义(P<0.05)。结论尿毒清颗粒能有效治疗慢性肾脏疾病,但大剂量使用效果更明显。 Objective To observe the clinical efficiency of Niaoduqing granules in treatment of chronic kidney disease 4. Methods 36 cases with CKD4 were randomly divided into control group,conventional doses group and large doses group. The control group was treated with basic treatment alone. The conventional doses group was added with oral uremic clearance granules 25 grams. The large doses group was added with oral uremic clearance granules 40 grams. All treated for 3 months. The serum of BUN,Scr,UA,Hb,e GFR were measured respectively before and after the treatment. Results There had significant difference in three groups of the clinical effect( P〈0. 05); the serum of BUN,Scr,UA,e GFR after the treatment of large doses group and conventional doses group decreased than before treatment,but no change in Hb. The serum of BUN,Scr,UA,e GFR after the treatment of large doses group and conventional doses group were significanct difference compared with control group( P〈0. 05). Conclusion Uremic Clearance granules can be effective in treating chronic kidney disease,large doses is more effective.
出处 《湖北中医药大学学报》 2015年第5期72-74,共3页 Journal of Hubei University of Chinese Medicine
关键词 慢性肾脏疾病 中西医结合疗法 尿毒清颗粒 chronic kidney disease TCM therapy western therapy Niaoduqing granules
  • 相关文献

参考文献10

  • 1谢敏妍,程正应,陈莎萍,朱理芬.尿毒清颗粒治疗慢性肾脏疾病述评[J].中国中西医结合肾病杂志,2010,11(7):657-658. 被引量:13
  • 2NN. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification [ J ]. Am J Kidney Dis, 2002,39(2suppl 1 ) : S1 -266.
  • 3袁丽君.尿毒清颗粒治疗慢性肾功能衰竭疗效观察[J].中外健康文摘,2011,8(25):241-242.
  • 4Zhang L, Zhang P, Wang F, et al. with CKD: a population study from 2008,51(3) :373 -384.
  • 5Prevalence and factors associated Beijing [ J ]. Am J Kidney Dis, Chen N,Wang W, Huang Y. Community -based study on CKD sub- jects and the associated risk factors [ J ]. Nephrol Dial Transplant, 2009,24(7 ) :2117 -2123.
  • 6Hooi Ls,Ong LM,Ahmad G,et al. A population -based study measur- ing the prevalence of chronic kidney disease among adults in West Ma- laysia[ J ]. Kidney international,2013,84 (5) : 1034 - 1040.
  • 7Lever AS, Stevens LA, Coresh J. Conceptual model of CKD: applica- tions and implications [ J ]. Am J Kidney Dis, 2009,53 ( 3 Suppl 3 ) : S4 -16.
  • 8谢志华,董建华.尿毒清颗粒延缓慢性肾衰竭的临床研究[J].中国中西医结合肾病杂志,2009,10(3):238-239. 被引量:35
  • 9丁瑞恒,廖蕴华.尿毒清防治慢性肾功能不全机制研究现状[J].医学综述,2010,16(10):1530-1532. 被引量:7
  • 10胡勤锦,闫振成.尿毒清联合ARB/ACEI治疗糖尿病肾病大量蛋白尿的疗效观察[J].重庆医学,2014,43(26):3436-3438. 被引量:36

二级参考文献46

共引文献86

同被引文献209

引证文献10

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部